Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

Korábbi kezelés

• Receiving ICU intervention (Non-invasive ventilation (including high flow nasal canula), invasive mechanical ventilation or inotropic support) for >18 hours
• Receiving IMV for airway protection only (for example, isolated head trauma)
• Patients receiving dialysis
• Previously enrolled in this trial

Más betegség

• Cardiac surgery patients

Laborértékek

• Patients requiring parenteral magnesium therapy (e.g. pre-eclampsia, asthma)

Életkor

• Positive pregnancy test (females <50 years old)

Egyéb

• Active atrial fibrillation at the time of enrolment
• On oral or continuous infusion of Amiodarone
• Unlikely to survive >24 hours or palliative patients
• Treating physician refuses enrollment

• Age ≥18 years;
• Admitted to an ICU with one or more of the following:
  • Non-invasive ventilation (including CPAP, Bipap and high flow oxygen (>10L/min) or invasive mechanical ventilation with an expected duration >24 hours for respiratory failure (hypercarbic or hypoxic)
  • Vasopressor or inotropic support with an expected duration of >24 hours
  • Cardiac arrest
• Continuous cardiac monitoring.